Asia Pacific Sleep Apnea Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Polysomnography (PSG) Device, Home Sleep Testing Devices, Oximeter, Actigraphy Monitoring Device, and Sleep Apnea Screening Device) and End User (Hospitals and Sleep Laboratories and Home Care Settings)
Market Introduction
The Asia Pacific Sleep apnea diagnostics market includes the consolidated markets for China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. Obstructive sleep apnea (OSA) is a sleep disease that affects a large number of Chinese people. Polysomnography is the gold standard for diagnosing OSA (PSG). Smart phone applications (apps) are now frequently used as a valuable source of health information. The quality of the information offered by these apps, on the other hand, has not been thoroughly evaluated. When compared to Caucasians, individuals of Chinese heritage appear to have OSA that is driven far more by their anatomical propensity and to a lesser extent by non-anatomical causes. PSG is offered in top-tier hospitals but not in primary care facilities in 2018, and when it is, it is frequently limited to a single department, limiting access for patients in other departments. According to population-based studies, at least 50 million Chinese people suffer from obstructive sleep apnea (OSA). The number of patients who received proper therapy and the types of therapies, on the other hand, are unknown.
A link between OSA and COVID-19 severity has been proposed based on parallels in pathophysiology and mutually promoting pathways that promote both infection risk and immune response to the virus. 8 OSA causes a cascade of persistent low-grade systemic inflammatory processes including oxidative stress as a result of increased creation and propagation of reactive oxygen species. The researchers looked at 4,668 patients with COVID-19, 443 of whom also had obstructive sleep apnea (OSA). Obstructive sleep apnea (OSA) was associated with a greater risk of overall mortality, both before any adjustment and after adjusting for demographics. Covid-19 has shown, as a chest specialist that it is one of the independent predictors of development of severe Covid pneumonia. Because any severe sleep apnea patient will have a very bad upper airway tone. There are many patients getting pneumonia in Covid-19, landing up in the ICU, just because they had sleep apnea and which was not treated. Covid-19 also has shown us that patient they have come with problem like snoring because many people started having psychological dyspnea, dyspnea means uncomfortable awareness of one's own breathing. There are more patients asking for getting themselves tested for sleep study. That's the new change which can be seen as clinicians. Changes imposed due to the pandemic have led to a surge in individuals reporting sleep problems. The findings raise the need to screen for worsening sleep patterns and use of sleeping aids, especially in more susceptible populations, namely, women and people with insecure livelihoods subjected to social isolation. With telehealth on the rise, those surveyed in Asia Pacific are open to online means to address sleep-related concerns, yet fear hinders many from getting tested for obstructive sleep apnea. The patient population and disease burden of sleep-disordered breathing (SDB), insomnia, and other sleeping disorders are quite high in China.
Market Overview and Dynamics
The sleep apnea diagnostics market in Asia Pacific is expected to grow US$ 106.92 million in 2021 to US$ 162.98 million by 2028; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028. Significant rise in the geriatric population has increased the prevalence of OSA. The occurrence of sleep apnea is more in the geriatric population due to presence of other related diseases. The higher occurrence of the OSA is attributed to the decline in the size of upper airway lumen due to increasing age factor. This factor is driving the sleep apnea diagnostics market substantially. Another key factor is the upsurge in the growing population. Several countries such as Japan, and developing countries such as China, India, and South Korea are experiencing significant growth in their geriatric population base. The growth of the geriatric population in these countries is driven by improved healthcare facilities and better healthcare services, leading increased life expectancy. Thus, the rise in geriatric population is among the key driving factors for the growth of the sleep apnea diagnostics market.
Key Market Segments
In terms of product, the polysomnography (PSG) device segment accounted for the largest share of the Asia Pacific sleep apnea diagnostics market in 2021. In term of end user, hospitals and sleep laboratories segment held a larger market share of the sleep apnea diagnostics market in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the sleep apnea diagnostics market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are ResMed, Inc.; Nihon Kohden Corporation LLC; SOMNOmedics GmbH; Cleveland Medical Devices Inc.; Koninklijke Philips N.V.; Natus Medical Incorporated; Itamar Medical Ltd.; Compumedics Limited; and Drive DeVilbiss International among others.
Reasons to buy report
- To understand the Asia Pacific sleep apnea diagnostics market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific sleep apnea diagnostics market
- Efficiently plan M&A and partnership deals in Asia Pacific sleep apnea diagnostics market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific sleep apnea diagnostics market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Asia Pacific region.
Asia Pacific Sleep Apnea Diagnostics Market Segmentation
Asia Pacific Sleep Apnea Diagnostics Market – By Product
- Polysomnography (PSG) Device
- Home Sleep Testing Devices
- Oximeter
- FingerTip Oximeter
- Handheld Oximeter
- Wrist-worn Oximeter
- Tabletop Oximeter
- Actigraphy Monitoring Device
- Sleep Apnea Screening Device
Asia Pacific Sleep Apnea Diagnostics Market – By End User
- Hospitals and Sleep Laboratories
- Home Care Settings
Asia Pacific Sleep Apnea Diagnostics Market – By Country
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
Asia Pacific Sleep Apnea Diagnostics Market – Companies Mentioned
- ResMed Inc.
- Nihon Kohden Corporation LLC
- SOMNOmedics GmbH
- Cleveland Medical Devices Inc.
- Koninklijke Philips N.V.
- Natus Medical Incorporated
- Itamar Medical Ltd.
- Compumedics Limited
- Drive DeVilbiss International
Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Sleep Apnea Diagnostics Market – By Product
1.3.2 Asia Pacific Sleep Apnea Diagnostics Market – By End User
1.3.3 Asia Pacific Sleep Apnea Diagnostics Market – By Country
2. Asia Pacific Sleep Apnea Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Sleep Apnea Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. Asia Pacific Sleep Apnea Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Fostering Prevalence of Sleep Apnea
5.1.2 Boosting Technological Developments
5.1.3 Increasing Geriatric Population
5.2 Market Restraints
5.2.1 High Charges of Diagnosis of Sleep Apnea
5.3 Market Opportunities
5.3.1 Surging Government Support for Medical Technologies
5.4 Future Trends
5.4.1 Boosting Scope Telemedicine
5.5 Impact Analysis
6. Asia Pacific Sleep Apnea Diagnostics Market Analysis
6.1 Asia Pacific Sleep Apnea Diagnostics Market Revenue Forecast and Analysis
7. Asia Pacific Sleep Apnea Diagnostics Market Analysis – By Product
7.1 Overview
7.2 Asia Pacific Sleep Apnea Diagnostics Market Share, by Product, 2021 and 2028 (%)
7.3 Polysomnography Devices
7.3.1 Overview
7.3.2 Polysomnography Devices: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Home Sleep Testing Devices
7.4.1 Overview
7.4.2 Home Sleep Testing Devices: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
7.5 Oximeters
7.5.1 Overview
7.5.2 Oximeters: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
7.5.3 Finger Tip Oximeter
7.5.3.1 Overview
7.5.3.2 Finger Tip Oximeter: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
7.5.4 Handheld Oximeter
7.5.4.1 Overview
7.5.4.2 Handheld Oximeter: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
7.5.5 Wrist-Worn Oximeter
7.5.5.1 Overview
7.5.5.2 Wrist-worn Oximeter: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
7.5.6 Tabletop Oximeter
7.5.6.1 Overview
7.5.6.2 Tabletop Oximeter: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
7.6 Actigraphy Monitoring Device
7.6.1 Overview
7.6.2 Actigraphy Monitoring Device: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
7.7 Sleep Apnea Screening Device
7.7.1 Overview
7.7.2 Sleep Apnea Screening Device: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Sleep Apnea Diagnostics Market Analysis – By End User
8.1 Overview
8.2 Asia Pacific Sleep Apnea Diagnostics Market Share, by End User, 2021 and 2028 (%)
8.3 Home Care Settings
8.3.1 Overview
8.3.2 Home Care Settings: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hospital and Sleep Laboratories
8.4.1 Overview
8.4.2 Hospital and Sleep Laboratories: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Sleep Apnea Diagnostics Market – Country Analysis
9.1 Overview
9.1.1 Asia Pacific: Sleep Apnea Diagnostics Market, by Country, 2021 & 2028 (%)
9.1.1.1 China: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 China: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 China: Sleep Apnea Diagnostics Market, by Product, 2019–2028 (USD Million)
9.1.1.1.2.1 China: Sleep Apnea Diagnostics Market, by Oximeter, 2019–2028 (USD Million)
9.1.1.1.3 China: Sleep Apnea Diagnostics Market, by End User, 2019–2028 (USD Million)
9.1.1.2 Japan: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 Japan: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 Japan: Sleep Apnea Diagnostics Market, by Product, 2019–2028 (USD Million)
9.1.1.2.2.1 Japan: Sleep Apnea Diagnostics Market, by Oximeter, 2019–2028 (USD Million)
9.1.1.2.3 Japan: Sleep Apnea Diagnostics Market, by End User, 2019–2028 (USD Million)
9.1.1.3 India: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 India: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 India: Sleep Apnea Diagnostics Market, by Product, 2019–2028 (USD Million)
9.1.1.3.2.1 India: Sleep Apnea Diagnostics Market, by Oximeter, 2019–2028 (USD Million)
9.1.1.3.3 India: Sleep Apnea Diagnostics Market, by End User, 2019–2028 (USD Million)
9.1.1.4 South Korea: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 South Korea: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 South Korea: Sleep Apnea Diagnostics Market, by Product, 2019–2028 (USD Million)
9.1.1.4.3 South Korea: Sleep Apnea diagnostics Market, by Oximeter, 2019–2028 (USD Million)
9.1.1.4.4 South Korea: Sleep Apnea diagnostics Market, by End User, 2019–2028 (USD Million)
9.1.1.5 Australia: Sleep Apnea diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.1 Australia: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2 Australia: Sleep Apnea Diagnostics Market, by Product, 2019–2028 (USD Million)
9.1.1.5.2.1 Australia: Sleep Apnea Diagnostics Market, by Oximeter, 2019–2028 (USD Million)
9.1.1.5.3 Australia: Sleep Apnea Diagnostics Market, by End User, 2019–2028 (USD Million)
9.1.1.6 Rest of Asia Pacific: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.1 Rest of Asia Pacific: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2 Rest of Asia Pacific: Sleep Apnea Diagnostics Market, by Product, 2019–2028 (USD Million)
9.1.1.6.2.1 Rest of Asia Pacific: Sleep Apnea Diagnostics Market, by Oximeter, 2019–2028 (USD Million)
9.1.1.6.3 Rest of Asia Pacific: Sleep Apnea Diagnostics Market, by End User, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Asia Pacific Sleep Apnea Diagnostics Market
10.1 Impact Assessment of COVID-19 Pandemic
11. Asia Pacific Sleep Apnea Diagnostics Market –Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Drive DeVilbiss International
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 ResMed Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Nihon Kohden Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 SOMNOmedics GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Cleveland Medical Devices Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke Philips N.V.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Natus Medical Incorporated
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Itamar Medical Ltd.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Compumedics Limited
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Sleep Apnea Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
Table 2. China: Sleep Apnea Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 3. China: Sleep Apnea Diagnostics Market, by Oximeter – Revenue and Forecast to 2028 (USD Million)
Table 4. China: Sleep Apnea Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Sleep Apnea Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 6. Japan: Sleep Apnea Diagnostics Market, by Oximeter – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Sleep Apnea Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 8. India: Sleep Apnea Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 9. India: Sleep Apnea Diagnostics Market, by Oximeter – Revenue and Forecast to 2028 (USD Million)
Table 10. India: Sleep Apnea Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 11. South Korea: Sleep Apnea Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 12. South Korea: Sleep Apnea diagnostics Market, by Oximeter – Revenue and Forecast to 2028 (USD Million)
Table 13. South Korea: Sleep Apnea diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 14. Australia: Sleep Apnea Diagnostics Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 15. Australia: Sleep Apnea Diagnostics Market, by Oximeter – Revenue and Forecast to 2028 (USD Million)
Table 16. Australia: Sleep Apnea Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Asia Pacific: Sleep Apnea Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Asia Pacific: Sleep Apnea Diagnostics Market, by Oximeter – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Asia Pacific: Sleep Apnea Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 20. Recent organic developments in the Sleep Apnea Diagnostics Market
Table 21. Inorganic Developments
Table 22. Glossary of Terms, sleep apnea devices market
LIST OF FIGURES
Figure 1. Asia Pacific Sleep Apnea Diagnostics Market Segmentation
Figure 2. Asia Pacific Sleep Apnea Diagnostics Market Segmentation, By Country
Figure 3. Asia Pacific Sleep Apnea Diagnostics Market Overview
Figure 4. Polysomnography (PSG) Device Held the Largest Share of the Product Segment in Asia Pacific Sleep Apnea Diagnostics Market
Figure 5. China to Show Significant Growth during Forecast Period
Figure 6. Asia Pacific Sleep Apnea Diagnostics Market, Industry Landscape
Figure 7. Asia Pacific PEST Analysis
Figure 8. Asia Pacific Sleep Apnea Diagnostics Market Impact Analysis of Driver and Restraints
Figure 9. Asia Pacific Sleep Apnea Diagnostics Market– Revenue Forecast and Analysis to 2028
Figure 10. Asia Pacific Sleep Apnea Diagnostics Market Share, by Product, 2021 and 2028 (%)
Figure 11. Polysomnography Devices: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Home Sleep Testing Devices: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. Oximeters: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Finger Tip Oximeter: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Handheld Oximeter: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Wrist-worn Oximeter: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. Tabletop Oximeter: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Actigraphy Monitoring Device: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. Sleep Apnea Screening Device: Sleep Apnea Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. Asia Pacific Sleep Apnea Diagnostics Market Share, by End User, 2021 and 2028 (%)
Figure 21. Home Care Settings: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Hospital and Sleep Laboratories: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Asia Pacific: Sleep Apnea Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 24. Asia Pacific: Sleep Apnea Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 25. China: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Japan: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. India: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. South Korea: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Australia: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Rest of Asia Pacific: Sleep Apnea Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Impact Of COVID-19 Pandemic in Asia Pacific Country Markets
- ResMed Inc.
- Nihon Kohden Corporation LLC
- SOMNOmedics GmbH
- Cleveland Medical Devices Inc.
- Koninklijke Philips N.V.
- Natus Medical Incorporated
- Itamar Medical Ltd.
- Compumedics Limited
- Drive DeVilbiss International
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific sleep apnea diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific sleep apnea diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the sleep apnea diagnostics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution